This article is available to members for free.

Goal: To increase awareness about smoking cessation therapy for patients with chronic kidney disease.

Objectives:

Explain how nicotine replacement therapy, bupropion, and varenicline are used as methods of smoking cessation therapy.
Describe the pharmacokinetics of bupropion and varenicline.
Discuss smoking cessation outcomes in patients with CKD.

Disclosure Statement: The authors reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Harold J. Manley PharmD, FASN, FCCP, BCPS

Appearances